Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 423-438 , October 2005

Papillary thyroid microcarcinoma: A surgical perspective

  • George H. Sakorafas

      Affiliations

    • Department of Surgery, 251 Hellenic Air Force Hospital, Arkadias 19-21, GR-11526 Athens, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 210 74 87 318; fax: + 30 210 74 87 192.
    • ,
  • John Giotakis

      Affiliations

    • Department of Otorinholaryngology, Medical School, Athens University, Athens, Greece
    • ,
  • Vania Stafyla

      Affiliations

    • Department of Surgery, 251 Hellenic Air Force Hospital, Arkadias 19-21, GR-11526 Athens, Greece

References 

  1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29
  2. In:  Hedinger C,  Williams ED editor. Histological typing of thyroid tumors. 2nd ed.. WHO international histological classification of tumours. vol. 11:Berlin: Springer; 1988;p. 9–10
  3. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary of the second edition. Cancer. 1989;63:908–911
  4. Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocrine Pathol. 2003;14:183–191
  5. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Atlas of tumor pathology. Third series, Fascicle 5, Washington, DC; 1992. p. 96–100.
  6. Tourniaire J, Bernard MH, Bizollon-Robin MH, et al. Papillary microcarcinoma of the thyroid. 179 cases reported since 1973. Press Med. 1998;27:1467–1469
  7. Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid microcarcinoma. A study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139–1146
  8. Nasir A, Chaudhry AZ, Gillespie J, Kaiser HE. Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review. In Vivo. 2000;14:367–376
  9. Schroder S, Pfannschmidt N, Bocker W, et al. Histopathologic types and clinical behavior of occult papillary thyroid carcinoma of the thyroid. Pathol Res Pract. 1984;179:81–87
  10. Paksoy N, Ozturk H, Demircan A, Artvinli M. Occult papillary carcinoma of the thyroid presenting as an endotracheal tumor. Eur J Surg Oncol. 1994;20:694–695
  11. Salvadori B, Del Bo R, Pilotti S, et al. “Occult” papillary carcinoma of the thyroid: a questionable entity. Eur J Cancer A. 1993;29:1817–1820
  12. Harach JR, Fransilla KO. Occult papillary carcinoma of the thyroid appearing as lung metastases. Arch Pathol Lab Med. 1984;108:529–530
  13. Allo MD, Christianson W, Kiovunen D. Not all “occult” papillary carcinoma are “minimal. Surgery. 1988;104:971–976
  14. Hubert JP, Kiernan PD, Beahrs OH, et al. Occult papillary carcinoma of the thyroid. Arch Surg. 1980;115:394–398
  15. Woolner LB, Lemmon ML, Beahrs OH, et al. Occult papillary carcinoma of the thyroid: a study of 140 cases observed in a 30-year period. J Clin Endocrinol. 1960;20:89–105
  16. Franssila KO, Harach HR. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer. 1986;58:715–719
  17. Bondenson L, Ljungberg O. Occult papillary thyroid carcinoma in the young and the aged. Cancer. 1984;53:1790–1792
  18. Bondenson L, Ljungberg O. Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer. 1981;47:319–323
  19. Boehm T, Rothouse L, Wartofsky L. Metastatic occult follicular thyroid carcinoma. J Am Med Assoc. 1976;235:2420–2421
  20. Yokozawa T, Fukata S, Kuma K, et al. Thyroid cancer detected by ultrasound-guided fine-needle aspiration biopsy. World J Surg. 1996;20:848–853
  21. Rodriguez JM, Moreno A, Parrilla P, et al. Papillary thyroid microcarcinoma: Clinical study and prognosis. Eur J Surg. 1997;163:255–259
  22. Sakorafas GH, Kassaras G, Stafyla V, et al. Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease. Presented at the 12th Congress of the European Society of Surgical Oncology, Budapest, Hungary, 31 March–3 April 2004.
  23. Sampson RJ, Key CR, Bucher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki. Prevalence of thyroid carcinoma at autopsy. J Am Med Assoc. 1969;209:65–70
  24. Sampson RJ, Oka H, Key CR, et al. Metastases from occult thyroid carcinoma; an autopsy study from Hiroshima and Nagasaki. Cancer. 1970;25:803–811
  25. Sampson RJ, Wootner LB, Bahn RC, et al. Occult thyroid carcinoma in Olmsted County, Minnesota; prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer. 1974;34:2072–2076
  26. Sobrinho-Simoes MA, Sambade MC, Goncalves V. Latent thyroid carcinoma at autopsy. A study from Oporto, Portugal. Cancer. 1979;43:1702–1706
  27. Harach HR, Franssila KO, Wasenius V. Occult papillary carcinoma of the thyroid; a “normal” finding in Finland. A systemic autopsy study. Cancer. 1985;56:531–538
  28. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol. 1988;90:72–76
  29. Ottino A, Pianazola HM, Castelleto RH. Occult papillary thyroid carcinoma in autopsy in La Plata, Argentina. Cancer. 1989;64:547–551
  30. Bisi H, Fernandes VSO, Asato de Camargo RY, et al. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies with special reference to the incidental carcinoma. Cancer. 1989;64:1888–1893
  31. Yamamoto Y, Maeta T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990;65:1173–1179
  32. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, et al. Occult carcinoma of the thyroid. A systemic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;71:4022–4029
  33. Fermanchuk AW, Roussak N, Ruchti C. Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy of 215 patients. Histopathology. 1993;23:319–325
  34. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg. 1996;83:1674–1683
  35. Appetecchia M, Scarcello G, Pucci E, Procaccini A. Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res. 2002;21:159–164
  36. Frantz VK. Lateral aberrant thyroids. Ann Surg. 1942;115:183–187
  37. Black BM. Papillary adenocarcinoma of the thyroid gland, so called lateral aberrant thyroid. World J Surg. 1948;56:134–144
  38. Wozencraft P, Foote FW, Frazell EL. Occult carcinomas of the thyroid: their bearing on the concept of lateral aberrant thyroid cancer. Cancer. 2003;1:574–583
  39. Fink A, Tomlinson G, Freeman JL, et al. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol. 1996;9:816–820
  40. David JM, Ruaux C, Bachaud JM, et al. Multiple localization and lymphatic involvement of papillary microcarcinoma of the thyroid. Results of thyroidectomy. Ann Oto-Laryngol Chir Cervico-Faciale. 1992;109:183–187
  41. Santini L, Gonzo G, Caraco C, et al. Papillary microcarcinoma of the thyroid. Ital Giorn Chirurg. 1996;17:488–492
  42. North JH. Thyroid carcinoma manifested as a cystic neck mass. South Med J. 1997;90:1027–1028
  43. Ferrario F, Roselli R, Macchi A. Occult thyroid carcinoma presenting as a parapharyngeal mass. J Laryngol Otol. 1995;109:1204–1206
  44. Hwang CF, Wu CM, Su CY, Cheng L. A long-standing cystic lymph node metastasis from occult thyroid carcinoma. J Laryngol Otol. 1992;106:932–934
  45. Michie HR, O’Bryan-Tear CG, Marsh H, Glazer G. Cerebral metastases from occult papillary carcinoma of the thyroid. Br J Surg. 1987;74:647
  46. Jancic-Zguricas M, Jankovic R. Occult papillary carcinoma of the thyroid gland revealed by cancer pericarditis. Pathol Res Pract. 1986;181:761–766
  47. Mills SE, Allen MS. Congenital occult papillary carcinoma of the thyroid gland. Hum Pathol. 1986;17:1179–1188
  48. Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer. 1984;54:1093–1100
  49. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinoma. Cancer. 1987;60:1767–1770
  50. Bondeson L, Ljungberg O. Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer. 1981;47:319–323
  51. Miki H, Oshimo K, Inoue H, et al. Diagnosis and surgical treatment of small papillary carcinomas of the thyroid gland. J Surg Oncol. 1993;54:78–81
  52. Kaleem Z, Dehner LP. Papillary microcarcinoma of the thyroid: a pathologist cancer. Mod Pathol. 1996;9:102A;(No 589)
  53. Rassael H, Thompson LD, Heffess CS. A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinicopathologic correlation of 90 cases. Eur Arch Otorhinolaryngol. 1998;255:462–467
  54. Lloyd RV, Bieierwaltes WH. Occult sclerosing carcinoma of the thyroid gland. South Med J. 1983;76:437–439
  55. Falvo L, D’Ercole C, Sorrenti S, et al. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg. 2002;(Suppl 588):28–32
  56. Pellegriti G, Scollo C, Lumera G, et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5cm in diameter: Study of 299 cases. J Clin Endocrinol Metab. 2004;89:3713–3720
  57. Hazard HB, Crile G, Dempsey WS. Nonencapsulated sclerosing tumors of the thyroid. J Clin Endocrinol. 1949;9:1216–1231
  58. Klinck GH, Winship T. Occult sclerosing carcinoma of the thyroid. Cancer. 1955;8:701–706
  59. Chan JK. Papillary carcinoma of the thyroid: classical and variants. Histol Histopathol. 1990;5:241–257
  60. Cady B. Primary carcinoma of the thyroid. Sem Surg Oncol. 1991;7:81–86
  61. Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: The Porto proposal. Int J Surg Pathol. 2003;11:249–251
  62. Johnson TL, Lloyd RV, Thompson NW, et al. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988;12:22–27
  63. Williams TL. Guest editorial. Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol. 2000;8:181–183
  64. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestation, pathologic findings, therapy and outcome. Mayo Clin Proc. 1986;61:978–996
  65. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–424
  66. Mazzaferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–428
  67. Schlumberger MJ. Papillary and follicular thyroid cancer. N Engl J Med. 1998;5:297–306
  68. Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocri Pract. 2000;6:469–476
  69. Chow SM, Law SC, Au SK, et al. Changes in clinical presentation, management, and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000. Clin Oncol. 2003;15:329–336
  70. Noguchi S. Differentiated thyroid carcinomas in Japan: our experience and review of the literature. Thyrodol Clin Exp. 1998;10:41–50
  71. Kamorowski RA, Hanson GA. Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol. 1988;19:689–696
  72. Siegal A, Modan M. Latent carcinoma of thyroid in Israel: a study of 260 autopsies. Israel J Med Sci. 1981;17:249–253
  73. Delides GS, Elemenoglu J, Lekkas J, Kittas CH, Evthimiou C. Occult thyroid carcinoma in a Greek population. Neoplasma. 1987;34:119–125
  74. Yamashita H, Nakayama I, Noguchi S, et al. Thyroid carcinoma in benign thyroid diseases. An analysis from minute carcinoma. Acta Pathol Jap. 1985;35:781–788
  75. Pelizzo MR, Piotto A, Rubello D, et al. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori (Milano). 1990;76:255–257
  76. Kawaura M, Pathak I, Gullane PJ, et al. Multicentricity in papillary thyroid carcinoma: analysis of predictive factors. J Otolaryngol. 2001;30:102–105
  77. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511–518
  78. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer. 1975;36:1095–1099
  79. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381–387
  80. Duffy GJ, Fitzgerald PJ. Thyroid cancer in childhood and adolescence. Cancer. 1950;3:1018–1022
  81. Wagner DH, Recant WM, Evans RH. A review of one hundred and fifty thyroidectomies following prior irradiation to the head, neck, and upper part of the chest. Surg Gynecol Obstet. 1978;147:903–908
  82. Hazard JB. Small papillary carcinoma of the thyroid: a study with special reference to the so-called nonencapsulated sclerosing tumor. Lab Invest. 1960;9:86–97
  83. Fukunaga FH, Lockett LJ. Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol. 1971;13:1971–1973
  84. Liu JD, Chao TC, Weng HF, et al. Clinical presentation and results of treatment of 74 occult thyroid carcinoma patients in North Taiwan. Am J Clin Oncol. 1996;19:504–508
  85. Iida F, Sugenoya A, Muramatsu A. Clinical and pathologic properties of small differentiated carcinomas of the thyroid gland. World J Surg. 1991;15:511–515
  86. Sugino K, Ito K, Ozaki O, et al. Papillary microcarcinoma of the thyroid. J Endocrinol Invest. 1998;21:445–448
  87. Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland. The Gustave Roussy Institute experience. Cancer. 1998;83:553–559
  88. Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805–828
  89. Jacques DA. Management of metastatic nodes in the neck from an unknown primary. In:  Paparella MM,  Schumrick D editor. Otolaryngology. 2nd ed.. Philadelphia: W.B. Saunders; 1980;p. 2999–3001
  90. Verge J, Guixa J, Alejo M, et al. Cervical cystic lymph node metastasis as first manifestation of occult papillary thyroid carcinoma: report of seven cases. Head Neck. 1999;21:370–374
  91. Seven H, Gurkan A, Cinar U, et al. Incidence of occult thyroid carcinoma metastases in lateral cervical cysts. Am J Otolarlyngol. 2004;25:11–17
  92. Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated?. World J Surg. 2004;28:1115–1121
  93. Patchefsky AS, Keller IB, Mansfield CM. Solitary vertebral column metastasis from occult sclerosing carcinoma of the thyroid gland: Report of a case. Am J Clin Pathol. 1970;53:596–601
  94. Terzioglu T, Tezelman S, Onaran Y, et al. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg. 1993;80:1301–1302
  95. Thyroid Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocrine Pract 2001;7:202–220.
  96. Yamashita H, Noguchi S, Murakami N, et al. Extracapsular invasion of lymph node metastasis – a good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer. 1999;86:842–849
  97. Tallini G, Asa SL. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol. 2001;8:345–354
  98. Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocrinol Pathol. 2002;13:3–16
  99. Sugg SL, Zheng L, Rosen IB, et al. RET/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?. J Endocrinol Metabol. 1996;81:3360–3365
  100. Viglietto G, Chiappetta G, Martinez-Tello FJ, et al. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene. 1995;11:1207–1210
  101. Santoro M, Papotti M, Chiappetta G, et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab. 2002;87:370–379
  102. Khoo ML, Freeman JL, Witterick IJ, et al. Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol-Head Neck Surg. 2002;128:253–257
  103. Khoo ML, Ezzat S, Freeman JL, et al. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab. 2002;87:1810–1813
  104. Bongarzone I, Pierotti MA. The molecular basis of thyroid epithelial tumorigenesis. Tumori. 2003;89:514–516
  105. Witterick IJ, Abel SM, et al. Nonpalpable occult and metastatic papillary thyroid carcinoma. Laryngoscope. 1993;103:149–155
  106. Senchenkov A, Staren ED. Ultrasound in head and neck surgery: thyroid, parathyroid and cervical lymph nodes. Surg Clin North Am. 2004;84:973–1000
  107. Mazzaferri EL. Management of solitary thyroid nodule. N Engl J Med. 1993;328:553–559
  108. Pearce EN, Braverman LE. Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab. 2004;89:3710–3712
  109. Solbiati L, Osti V, Cova L, Tonolini M. Ultrasound of thyroid, parathyroid glands, and neck lymph nodes. Eur Radiol. 2001;11:2411–2424
  110. Takebe K, Date M, Yamamoto Y, et al. Mass screening for thyroid cancer with ultrasonography [Jpn]. Karkinos. 1994;7:309–317
  111. Yokozawa T, Miyauchi A, Kuma K, et al. Accurate and simple method of diagnosing thyroid nodules by the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid. 1995;5:141–145
  112. Ishida T, Izuo M, Ogawa T, et al. Evaluation of mass screening for thyroid cancer. Jap J Clin Oncol. 1988;18:289–295
  113. Takami H, Kodaira S. A rapid immunoperoxidase method for pathological diagnosis of occult thyroid carcinoma. Int Surg. 1993;78:225–228
  114. Perez J, Silva R, del Pozo M, Henning F. Diffuse hypertrophied goiter associated with occult papillary carcinoma of the thyroid. Revista Med Chile. 1994;122:201–205
  115. Sugitani I, Fujimoto Y. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J. 1999;46:209–216
  116. Belfiore A, Russo D, Vigneri R, Filetti S. Grave’s disease, thyroid nodules, and thyroid cancer. Clin Endocrinol. 2001;55:711–718
  117. De Jong SA, Demeter JG, Jarosz H, et al. Primary papillary thyroid carcinoma presenting as cervical lymphadenopathy: the operative approach to the “lateral aberrant thyroid. Am Surg. 1993;59:172–176
  118. Rodier JF, Janser JC. Cervical lymphadenopathy revealing differentiated thyroid cancer; review of the literature and therapeutic approach [French]. Ann Chir. 1998;52:922–966
  119. Loughran CE. Solitary cystic nodal metastasis from occult papillary carcinoma of the thyroid mimicking a branchial cyst – a potential pitfall. Clin Radiol. 1998;53:465
  120. Levy I, Barki Y, Tovi F, et al. Cystic metastases of the neck from occult thyroid adenocarcinoma. Am J Surg. 1992;163:298–300
  121. Gikas PW, Labow SS, DiGulia W, et al. Occult metastasis from occult papillary carcinoma of the thyroid. Cancer. 1967;20:2100–2104
  122. Sasaki H, Sirakusa T, Suzuki K, et al. Occult papillary carcinoma of the thyroid presenting as a solitary pulmonary metastasis. [Jpn] Nippon Naibunpi Gakkai ZashiFolia Endocrinologica Japonica. 1991;67:655–665
  123. Fend F, Gruber U, Fritzsche M, et al. Occult papillary carcinoma of the thyroid with pulmonary lymphangiitic spread diagnosed by lung biopsy. Klinische Wochenschrift. 1989;67:687–690
  124. Laskin WB, James LP. Occult papillary carcinoma of the thyroid with pulmonary metastases. Hum Pathol. 1983;14:83–85
  125. Ito J, Noguchi S, Murakami N, Noguchi A. Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet. 1980;150:539–544
  126. Vickery AL, Wang CA, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer. 1987;60:2587–2595
  127. Cohn KH, Backdahl M, Forsslund G, et al. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy. Surgery. 1984;96:957–971
  128. Farkas EA, King TA, Bolton JS, Fuhrman GM. A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules. Am Surg. 2002;68:678–682
  129. Bhattacharya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg. 2002;128:389–392
  130. Mazzaferri EL, Kloos RT. Clinical review: current approach to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–1462
  131. Nagouchi S, Yamashita M, Murakami N, et al. Small carcinomas of the thyroid. A long term follow-up of 876 patients. Arch Surg. 1996;13:187–191
  132. Kupferman ME, Mandel SJ, DiDonato L, et al. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope. 2002;112:1209–1212
  133. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794–804
  134. Giles Y, Boztepe H, Terzioglou T, Tezlman S. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg. 2004;139:179–182
  135. Marchesi M, Biffoni M, Faloci C, et al. High rate of recurrence after lobectomy for solitary thyroid nodule. Eur J Surg. 2002;168:397–400
  136. Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am. 1998;31:823–831
  137. Bottger T, Klupp J, Cabert HE, Junginger T. Prognostically relevant factors in papillary thyroid cancer. Med Klin. 1991;86:76–82
  138. Sampson RJ, Key CR, Buncher CR, Iijima S. Smallest forms of papillary carcinoma of the thyroid. Arch Pathol. 1971;91:334–339
  139. Tsuchiya A, Suzuki S, Kanno M, et al. Prognostic factors associated with differentiated thyroid cancer. Surg Tod. 1995;25:778–782
  140. Christensen SB, Ljungberg O, Tibblin S. Surgical treatment of thyroid carcinoma in a defined population: 1960 to 1977. Evaluation of the results after a conservative surgical approach. Am J Surg. 1983;146:349–354
  141. Rossi RL, Cady B, Silverman ML, et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg. 1986;10:612–622
  142. Noguchi S, Yamashita H, Murakami N, et al. Small carcinomas of the thyroid. A long term follow-up of 867 patients. Arch Surg. 1996;131:187–191
  143. Ceccarelli C, Pacini F, Lippi F, et al. Thyroid cancer in children and adolescents. Surgery. 1988;104:1143–1148
  144. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–950
  145. Park CS, Min JS. Lateral neck mass as the initial manifestation of thyroid carcinoma. Head Neck. 1989;11:410–413
  146. Schroder DM, Chambors A, France CJ. Operative strategy for thyroid cancer. Is total thyroidectomy worth the price?. Cancer. 1986;58:2320–2328
  147. Satge D, Grob JC, Pusel J, Methlin G. Microcarcinoma thyroidienne d’ evolution fatale. Arch Anat Cytol Pathol. 1990;38:143–151
  148. Woolner LB, Beahrs OH, Black BM, et al. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a 30-year period. Am J Surg. 1961;102:354–387
  149. Lissak B, Vannetzel JM, Gallouedec N, et al. Solitary skin metastasis as the presenting feature of differentiated thyroid microcarcinoma: report of two cases. J Endocrinol Invest. 1995;18:813–816
  150. Lin KD, Lin JD, Huang MJ, et al. Clinical presentations and predictive variable of thyroid microcarcinoma with distant metastases. Int Surg. 1997;82:378–381
  151. Sugitani I, Yanagisawa A, Shimizu A, et al. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg. 1998;22:731–737
  152. Fujimoto Y, Obara T, Ito Y, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study. Cancer. 1990;66:2306–2310
  153. Brown DC, Gatter KC. Monoclonal antibody Ki-67; its use in histopathology. Histopathology. 1990;17:489
  154. Soda G, Antonaci A, Bosco D, et al. Expression of bcl-2, c-erbB-2, p53, and p21 (wafl-cip1) protein in thyroid carcinomas. J Exp Clin Cancer Res. 1999;18:363–367
  155. Stocker DJ, Burch HB. Thyroid cancer yield in patients with Grave’s disease. Minerva Endocrinol. 2003;28:205–212
  156. Lupoli G, Vitale G, Garaglia M, et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet. 1999;353:637–639
  157. Haigh PI, Urbach DR, Rotstein LE. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery. 2004;136:609–616
  158. Voutilainen PE, Siironen P, Franssila KO, et al. AMES, MACIS, and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res. 2003;23:4283–4288
  159. Frauenhoffer CM, Patchefsky AS, Cobanoglu A. Thyroid carcinoma, a clinical and pathologic study of 125 cases. Cancer. 1979;43:2414–2421
  160. Cailleux AF, Baudin E, Travagli IP, et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?. J Clin Endocrinol Metab. 2000;85:175–178

PII: S0305-7372(05)00083-6

doi: 10.1016/j.ctrv.2005.04.009

Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 423-438 , October 2005

Article Tools